PH23436A - 1,4-dihydropyridine derivatives,in optically active or racemate form and their pharmaceutical compositions - Google Patents
1,4-dihydropyridine derivatives,in optically active or racemate form and their pharmaceutical compositionsInfo
- Publication number
- PH23436A PH23436A PH29057A PH29057A PH23436A PH 23436 A PH23436 A PH 23436A PH 29057 A PH29057 A PH 29057A PH 29057 A PH29057 A PH 29057A PH 23436 A PH23436 A PH 23436A
- Authority
- PH
- Philippines
- Prior art keywords
- pharmaceutical compositions
- optically active
- dihydropyridine derivatives
- racemate form
- racemate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH369382 | 1982-06-15 | ||
CH369282 | 1982-06-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH23436A true PH23436A (en) | 1989-08-07 |
Family
ID=25693638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH29057A PH23436A (en) | 1982-06-15 | 1983-06-14 | 1,4-dihydropyridine derivatives,in optically active or racemate form and their pharmaceutical compositions |
Country Status (19)
Country | Link |
---|---|
AU (1) | AU1575383A (es) |
BE (1) | BE897000A (es) |
CA (1) | CA1208639A (es) |
CH (1) | CH660593A5 (es) |
DE (1) | DE3320616A1 (es) |
DK (1) | DK271183A (es) |
ES (2) | ES8504179A1 (es) |
FI (1) | FI832072L (es) |
FR (1) | FR2528431B1 (es) |
GB (1) | GB2122192B (es) |
HU (1) | HU191853B (es) |
IT (1) | IT1178353B (es) |
NL (1) | NL8302067A (es) |
NZ (1) | NZ204536A (es) |
PH (1) | PH23436A (es) |
PT (1) | PT76870B (es) |
SE (1) | SE8303385L (es) |
WO (1) | WO1984000033A1 (es) |
ZA (1) | ZA834409B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3431152A1 (de) * | 1984-08-24 | 1986-03-06 | Cassella Ag, 6000 Frankfurt | Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel |
GB8428552D0 (en) * | 1984-11-12 | 1984-12-19 | Sandoz Ltd | Organic compounds |
US5260321A (en) * | 1984-11-12 | 1993-11-09 | Sandoz Ltd. | Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins |
DE3447169A1 (de) * | 1984-12-22 | 1986-07-03 | Bayer Ag, 5090 Leverkusen | Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln |
US4920225A (en) * | 1986-12-22 | 1990-04-24 | Laboratoires Syntex S.A. | Resolution of 1,4-dihydropyridine derivatives |
DE3809912A1 (de) * | 1987-03-27 | 1988-10-27 | Byk Gulden Lomberg Chem Fab | Neue zwischenprodukte zur herstellung von 1,4-dihydropyridin-3,5-dicarbonsaeurederivaten |
DE4041814A1 (de) * | 1990-12-24 | 1992-07-02 | Byk Gulden Lomberg Chem Fab | Verfahren zur herstellung von dihydrophyridincarbonsaeuren |
US5135936A (en) * | 1991-03-05 | 1992-08-04 | Marion Merrell Dow Inc. | Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists |
CN100425599C (zh) * | 2005-12-31 | 2008-10-15 | 清华大学 | 一种有机电致发光材料及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI64938C (fi) * | 1977-06-20 | 1984-02-10 | Sandoz Ag | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat |
CH639659A5 (de) * | 1978-12-18 | 1983-11-30 | Sandoz Ag | Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung. |
DE2949464A1 (de) * | 1978-12-18 | 1980-06-26 | Sandoz Ag | Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung |
FI813460L (fi) * | 1980-11-10 | 1982-05-11 | Sandoz Ag | Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner |
-
1983
- 1983-06-07 FR FR8309551A patent/FR2528431B1/fr not_active Expired
- 1983-06-08 DE DE3320616A patent/DE3320616A1/de not_active Withdrawn
- 1983-06-08 FI FI832072A patent/FI832072L/fi not_active Application Discontinuation
- 1983-06-09 BE BE1/10806A patent/BE897000A/fr not_active IP Right Cessation
- 1983-06-10 NL NL8302067A patent/NL8302067A/nl not_active Application Discontinuation
- 1983-06-10 CH CH688/84A patent/CH660593A5/de not_active IP Right Cessation
- 1983-06-10 WO PCT/CH1983/000073 patent/WO1984000033A1/de unknown
- 1983-06-13 IT IT48488/83A patent/IT1178353B/it active
- 1983-06-13 NZ NZ204536A patent/NZ204536A/en unknown
- 1983-06-13 CA CA000430300A patent/CA1208639A/en not_active Expired
- 1983-06-13 GB GB08316054A patent/GB2122192B/en not_active Expired
- 1983-06-13 DK DK271183A patent/DK271183A/da not_active Application Discontinuation
- 1983-06-14 PH PH29057A patent/PH23436A/en unknown
- 1983-06-14 HU HU832113A patent/HU191853B/hu unknown
- 1983-06-14 ES ES523243A patent/ES8504179A1/es not_active Expired
- 1983-06-14 SE SE8303385A patent/SE8303385L/xx not_active Application Discontinuation
- 1983-06-14 AU AU15753/83A patent/AU1575383A/en not_active Abandoned
- 1983-06-14 PT PT76870A patent/PT76870B/pt unknown
- 1983-06-15 ZA ZA834409A patent/ZA834409B/xx unknown
-
1984
- 1984-11-30 ES ES538157A patent/ES8604578A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CH660593A5 (de) | 1987-05-15 |
FR2528431A1 (fr) | 1983-12-16 |
ZA834409B (en) | 1985-02-27 |
WO1984000033A1 (en) | 1984-01-05 |
NZ204536A (en) | 1986-09-10 |
GB2122192B (en) | 1985-12-18 |
AU1575383A (en) | 1983-12-22 |
SE8303385L (sv) | 1983-12-16 |
HU191853B (en) | 1987-04-28 |
DK271183A (da) | 1983-12-16 |
ES8604578A1 (es) | 1986-02-01 |
IT8348488A0 (it) | 1983-06-13 |
ES538157A0 (es) | 1986-02-01 |
FI832072A0 (fi) | 1983-06-08 |
PT76870B (en) | 1986-02-27 |
CA1208639A (en) | 1986-07-29 |
ES523243A0 (es) | 1985-04-01 |
FR2528431B1 (fr) | 1986-01-10 |
SE8303385D0 (sv) | 1983-06-14 |
PT76870A (en) | 1983-07-01 |
NL8302067A (nl) | 1984-01-02 |
GB2122192A (en) | 1984-01-11 |
IT1178353B (it) | 1987-09-09 |
FI832072L (fi) | 1983-12-16 |
DE3320616A1 (de) | 1983-12-15 |
GB8316054D0 (en) | 1983-07-20 |
BE897000A (fr) | 1983-12-09 |
ES8504179A1 (es) | 1985-04-01 |
DK271183D0 (da) | 1983-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ212895A (en) | 1,4-dihydropyridine derivatives and pharmaceutical compositions | |
IL60937A (en) | Optically active 1,4-dihydropyridine compounds,their production and pharmaceutical compositions containing them | |
DE3265978D1 (en) | 1,4-dihydropyridine derivative and pharmaceutical composition containing same | |
EP0161877A3 (en) | 1,4-dihydropyridine derivatives, methods for their production and pharmaceutical compositions comprising the same | |
IL73706A0 (en) | 2,2'-iminobisethanol derivatives,their preparation and pharmaceutical compositions containing them | |
IL76405A (en) | 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them | |
NZ222030A (en) | Substituted imidazo-(5,4-g (3,1 benzoxaminone derivatives and pharmaceutical compositions | |
IL71187A0 (en) | 1,4-dihydropyridine derivatives and pharmaceutical compositions containing them | |
IL63368A0 (en) | 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines,their preparation and pharmaceutical compositions containing them | |
IL75943A (en) | 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them | |
IL72562A (en) | 6,7-dimethoxy-4-piperidino-quinazoline derivatives and pharmaceutical compositions containing them | |
NZ226516A (en) | 2,2 dimethylchromene derivatives and pharmaceutical compositions | |
PH23436A (en) | 1,4-dihydropyridine derivatives,in optically active or racemate form and their pharmaceutical compositions | |
IL72152A0 (en) | 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them | |
NZ214088A (en) | 1,3-diazoles and pharmaceutical compositions | |
IL64563A0 (en) | 3,4-bis-substituted 1,2,5-oxidiazole 2-oxides,their preparation and pharmaceutical compositions containing them | |
IL64252A (en) | 3,3-dimethyl-indolin-2-ones,their preparation and pharmaceutical compositions containing them | |
IL68970A0 (en) | Antiarteriosclerotic compositions containing 1,4-dihydropyridines and their preparation | |
AU3454984A (en) | 1,z-dithiolanes and pharmaceutical compositions | |
PT84339A (pt) | 1,6-naphthyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them | |
NZ227235A (en) | Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions | |
NZ216555A (en) | 1,4-dihydropyridine derivatives and pharmaceutical compositions | |
NZ218087A (en) | 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and pharmaceutical compositions | |
IL85254A0 (en) | 14,15-substituted lanosterols and pharmaceutical compositions containing them | |
IL89377A0 (en) | Substituted imidazolinones and imidazolinethiones,their preparation and pharmaceutical compositions containing them |